Stay updated on Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page.

Latest updates to the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded Revision: v3.4.2. Removed references to Lung cancer, related topics, MedlinePlus Genetics, and Revision: v3.4.1.SummaryDifference0.1%

- Check31 days agoChange DetectedRevision: v3.4.1 was added, and Lung cancer, related topics, MedlinePlus Genetics, and Revision: v3.4.0 were removed.SummaryDifference0.1%

- Check45 days agoChange DetectedUI text updates include added options to show or hide the glossary, and new labels 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Old items such as 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page shows a new revision label v3.3.4 replacing v3.3.3; no substantive study information was altered.SummaryDifference0.0%

- Check76 days agoChange DetectedLocations where the trial is conducted were updated, with additions of numerous site locations and related topics such as MedlinePlus Genetics. Several location-specific entries were removed.SummaryDifference2%

Stay in the know with updates to Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page.